This Article Full Text Full Text (PDF) Data Supplement Correction (v117,pe19) All Versions of this Article: 116/22/2587    most recent CIRCULATIONAHA.107.711317v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Frank, D. Articles by Frey, N. Search for Related Content PubMed PubMed Citation Articles by Frank, D. Articles by Frey, N. Related Collections Cell signalling/signal transduction Genetically altered mice Hypertrophy Physiological and pathological control of gene expression

(Circulation. 2007;116:2587-2596.)
© 2007 American Heart Association, Inc.

Molecular Cardiology

Calsarcin-1 Protects Against Angiotensin-II–Induced Cardiac Hypertrophy

Derk Frank, MD^*; Christian Kuhn, MD^*; Martin van Eickels, MD; Doris Gehring, BS; Christiane Hanselmann, BS; Stefanie Lippl, BS; Rainer Will, PhD; Hugo A. Katus, MD; Norbert Frey, MD

From the Department of Internal Medicine III (D.F., C.K., C.H., S.L., R.W., H.A.K., N.F.), University of Heidelberg, Germany; Medizinische Universitäts-Poliklinik (M.v.E.), Universitätsklinikum Bonn, Germany; and Sanofi-Aventis Pharma (D.G.), Frankfurt, Germany.

Correspondence to Dr Norbert Frey, Medizinische Universitätsklinik Heidelberg, Department of Internal Medicine III, Im Neuenheimer Feld 410, D-69120 Heidelberg, Germany. E-mail norbert.frey{at}med.uni-heidelberg.de

Received April 25, 2007; accepted September 21, 2007.

Background— We have previously shown that deficiency for the z-disc protein calsarcin-1 (CS1) sensitizes the heart to calcineurin signaling and to stimuli of pathological hypertrophy. In the present study we asked whether overexpression of CS1 might exhibit antihypertrophic effects, and therefore we tested this hypothesis both in vitro and in vivo.

Methods and Results— Adenoviral gene transfer of CS1 into neonatal cardiomyocytes inhibited hypertrophy as a result of Gq-agonist stimulation, including angiotensin-II (Ang-II), endothelin-1, and phenylephrine. Consistently, Adenoviral gene transfer of CS1 also led to the reduction of increased levels of atrial natriuretic factor (mRNA) and the calcineurin-sensitive gene MCIP1.4, suggesting that CS1 inhibits calcineurin-dependent signaling. Furthermore, we generated CS1-overexpressing transgenic mice (CS1Tg). Unchallenged CS1Tg mice did not exhibit a pathological phenotype as assessed by echocardiography and analysis of cardiac gene expression. Likewise, when subjected to long-term infusion of Ang-II, both CS1Tg and wild-type mice developed a similar degree of arterial hypertension. Yet, in contrast to wild-type mice, Ang-II–treated CS1Tg animals did not display cardiac hypertrophy. Despite the absence of hypertrophy, both fractional shortening and dP/dt_max were preserved in CS1Tg Ang-II–treated mice as assessed by echocardiography and cardiac catherization, respectively. Moreover, induction of the hypertrophic gene program (atrial natriuretic factor, brain natriuretic peptide) was markedly blunted, and expression of the calcineurin-dependent gene MCIP1.4 was significantly reduced in CS1Tg mice, again consistent with an inhibitory role of CS1 on calcineurin.

Conclusions— The sarcomeric protein CS1 prevents Ang-II–induced cardiomyocyte hypertrophy at least in part via inhibition of calcineurin signaling. Thus, overexpression of CS1 might represent a novel approach to attenuate pathological cardiac hypertrophy.

---

 

CLINICAL PERSPECTIVE

This article has been cited by other articles:

				K. Fujita, N. Maeda, M. Sonoda, K. Ohashi, T. Hibuse, H. Nishizawa, M. Nishida, A. Hiuge, A. Kurata, S. Kihara, et al. Adiponectin Protects Against Angiotensin II-Induced Cardiac Fibrosis Through Activation of PPAR-{alpha} Arterioscler. Thromb. Vasc. Biol., May 1, 2008; 28(5): 863 - 870. [Abstract] [Full Text] [PDF]